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Abstract
Introduction Bacteria and/or their antigens have been
implicated in the pathogenesis of reactive arthritis (ReA).
Several studies have reported the presence of bacterial
antigens and nucleic acids of bacteria other than those
specified by diagnostic criteria for ReA in joint specimens from
patients with ReA and various arthritides. The present study was
conducted to detect any bacterial DNA and identify bacterial
species that are present in the synovial tissue of Tunisian
patients with reactive arthritis and undifferentiated arthritis (UA)
using PCR, cloning and sequencing.
Methods We examined synovial tissue samples from 28
patients: six patients with ReA and nine with UA, and a control
group consisting of seven patients with rheumatoid arthritis and
six with osteoarthritis (OA). Using broad-range bacterial PCR
producing a 1,400-base-pair fragment from the 16S rRNA gene,
at least 24 clones were sequenced for each synovial tissue
sample. To identify the corresponding bacteria, DNA sequences
were compared with sequences from the EMBL (European
Molecular Biology Laboratory) database.
Results Bacterial DNA was detected in 75% of the 28 synovial
tissue samples. DNA from 68 various bacterial species were
found in ReA and UA samples, whereas DNA from 12 bacteria
were detected in control group samples. Most of the bacterial
DNAs detected were from skin or intestinal bacteria. DNA from
bacteria known to trigger ReA, such as Shigella flexneri and
Shigella sonnei, were detected in ReA and UA samples of
synovial tissue and not in control samples. DNA from various
bacterial species detected in this study have not previously been
found in synovial samples.
Conclusion This study is the first to use broad-range PCR
targeting the full 16S rRNA gene for detection of bacterial DNA
in synovial tissue. We detected DNA from a wide spectrum of
bacterial species, including those known to be involved in ReA
and others not previously associated with ReA or related
arthritis. The pathogenic significance of some of these
intrasynovial bacterial DNAs remains unclear.
Introduction
Bacteria are considered to be important in the pathogenesis
of several forms of arthritis, including reactive arthritis (ReA)
[1] or various other forms of post-infectious arthritis [2]. ReA
is defined as an inflammatory arthritis, occurring approximately
4 weeks after an infection, with no cultivable bacteria detecta-
EMBL = European Molecular Biology Laboratory; OA = osteoarthritis; PCR = polymerase chain reaction; RA = rheumatoid arthritis; ReA = reactive 
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ble in the joints [3,4]. Usually, the initial arthritogenic bacterial
infection affects the urogenital tract (for example, Chlamydia
trachomatis) or the digestive tract (Yersinia,  Salmonella  or
Shigella spp., or Campylobacter jejeuni) [4]. ReA can also fol-
low respiratory tract infections with Chlamydophila pneumo-
niae [5].
Many cases of ReA are preceded by infections that are asymp-
tomatic [6]; such cases are clinically classified as undifferenti-
ated arthritis (UA) [7,8]. This term describes patients who
exhibit arthritis clinically similar to ReA, with high rates of
monoarthritis or oligoarthrithis, and predominance of synovitis
in the lower limbs. This has led several investigators to suggest
a potential link between these two forms of arthritis, and that
UA and ReA are overlapping entities. Several groups have
detected C. trachomatis DNA in the synovium of patients with
UA [9], suggesting that some of these patients may have a
'forme fruste' of ReA.
Arthritogenic bacterial DNA and RNA from Chlamydia tracho-
matis, Chlamydophila pneumoniae, and Yersinia pseudotu-
berculosis have been detected by PCR in synovial samples
from patients with ReA and UA. Thus, micro-organisms, or
components thereof, do reach the joint but are not always cul-
tivable [2,9-12]. This suggests that inflammation at the joint is
caused by an immune response to bacterial antigens [9,13].
Bacterial DNA has also been detected in synovial samples
from patients with other forms of arthritis, such as rheumatoid
arthritis (RA) or osteoarthritis (OA) [14-16]. Detection of
nucleic acids from other bacteria (Pseudomonas sp., Bacillus
cereus, Mycobacterium tuberculosis, or Borrelia burgdorferi)
in synovial fluid or synovial tissue (ST) from patients with ReA
or other forms of arthritis (UA, RA, or OA) has raised the ques-
tion of whether non-Chlamydia  or nonenteric bacteria may
enter the synovium and cause or contribute toward synovitis
[14,17-19]. However, the list of pathogens that trigger ReA is
not definitively established.
Several studies have addressed this issue, using broad-range
PCR and/or reverse transcription PCR systems to search for
bacterial DNA and RNA in synovial samples from patients with
various forms of arthritis, including ReA [12,14,17]. By cloning
and sequencing the PCR products, they have shown that
more than one micro-organism can be present in the same
joint. In most studies, the PCR products were of sufficient
length to determine the genus of the bacteria in the synovial
samples, but were not long enough to identify the species level
[12,17].
In this study we aimed to identify bacterial DNA in patients with
ReA and UA using broad-range PCR, cloning and sequencing
of almost the entire 16S rRNA gene. The use of this approach
revealed the identity of potential bacterial causes and the pres-
ence of previously uncharacterized and uncultured bacterial
pathogens in joint disease. Despite the frequent occurrence of
genital and intestinal infections in Tunisia [20-24], no studies
of ReA-related bacteria have yet been conducted in this coun-
try.
Materials and methods
Patients
Twenty-eight patients with knee effusion, who had given
informed consent, were included in the study after approval
from our institutional review board. All patients were attending
one of three rheumatology hospital departments in Tunisia. ST
samples were obtained by needle biopsy from six patients with
ReA (six posturethritic) and nine with UA, and from a control
group of seven patients with RA and six with OA. The patients'
clinical features and demographic characteristics are summa-
rized in Table 1.
ReA was diagnosed according to European Spondyloarthrop-
athy Study Group and Amor criteria [25,26]. All of the cases
of ReA were acquired sexually, with arthritis occurring within 4
weeks of an urogenital infection (Table 1). UA was defined as
a monoarthritis or oligoarthritis occurring without evidence of
a predisposing infection in a patient in whom other known
rheumatic diseases had been excluded.
ST samples were taken from the knee joint using the Parker-
Pearson biopsy procedure [27]. Care was taken during and
after obtaining patient samples to prevent cutaneous bacterial
contamination. The skin surface was prepared with three suc-
cessive betadine solution swabs, each for 2 minutes, and then
with 70% alcohol for 2 minutes, before sampling. ST samples
were immediately placed in sterile microcentrifuge tubes,
which were closed and snap frozen in liquid nitrogen. Tubes
were stored at -80°C until analysis.
Automated DNA extraction
A DNA extraction procedure using the MagNA Pure system
(Roche Molecular Biochemicals, Meylan, France) was used for
all ST samples, using a pre-extraction treatment. Before
MagNA Pure extraction, 500 μl lysis buffer (200 mmol/l NaCl,
20 mmol/l Tris HCl [pH 8], 50 mmol/l EDTA, and 1% SDS)
and 25 μl proteinase K (10 mg/ml; Sigma, St Louis, MO, USA)
were added to approximately 10 mg of ST. The mixture was
then vigorously agitated and incubated at 65°C for 30 minutes
or until complete dissociation of the ST fragments. The enzy-
matic reaction was stopped by incubation at 95°C for 10 min-
utes and samples were centrifuged at 10,000 g for 5 seconds.
DNA was extracted on the MagNA Pure instrument using the
MagNA Pure LC DNA isolation kit-Large Volume, in accord-
ance with the manufacturer's instructions.
Broad-range PCR amplification of 16S rRNA genes
The full-length 16S rRNA gene was amplified from extracted
DNA with broad range primers (BAc08F: 5'-AGAGTTTGATC-
CTGGCTCAG-3'; and Uni 1390R: 5'-GACGGGCGGTGT-
GTA CAA-3'), targeting the region corresponding toAvailable online http://arthritis-research.com/content/10/2/R40
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nucleotides 8 to 27 and 1,390 to 1,407 of the Escherichia coli
16S rRNA gene [28,29]. DNA was amplified in 50 μl reaction
mixtures, each containing 1× Ex Taq Buffer (Takara Ex taq,
Otsu, Shiga, Japan), 0.2 mmol/l of each primer, 2.5 mmol/l of
each DNTP, 2 mmol/l MgCl2 and 1.25 units of Takara Ex Taq
DNA polymerase (Takara Ex taq, Otsu, Shiga, Japan. T4 Gene
32 Protein (5 μg/μl; USB Corp, Cleveland, Ohio) was added
to the PCR mix followed by 2.5 μl of DNA extract. PCR was
performed as follows: initial denaturation at 94°C for 5 min-
utes, followed by 30 cycles of denaturation at 94°C for 1
minute, primer annealing at 59°C for 1 minute and extension at
72°C for 1.5 minutes. The final elongation step was extended
to 15 minutes. PCR was carried out in a Gene-Amp PCR Sys-
tem 9700 (Applied Biosystems, Foster City, CA, USA). All
extracts were tested undiluted, diluted 1:10 and 1:20, with or
without T4 Gene 32 Protein, to avoid false-negative results.
The T4 Gene 32 Protein was used to increase the yield of
PCR products [30-32].
Pure DNA from either E. coli or C. trachomatis was used as a
positive control for the broad-range PCR screening system.
Amplification products were visualized on ethidium bromide-
stained 1% Seakem GTG agarose gel (Tebu-bio, Le Perray en
Yvelines, France).
Precautionary measures were taken to prevent DNA contami-
nation during DNA extraction and manipulation. These
included pipeting PCR components under a laminar flow of
sterile air, using only sterile equipments, dedicated pre-PCR
and post-PCR rooms, and dedicated sets of pipettes, dispos-
able gloves, laboratory coats and non-reusable waste contain-
ers. Reagents and PCR primers were aliquoted to prevent
frequent handlings. DNA extraction was performed in two sep-
arated biological hoods, which were cleaned before and after
each sample preparation with 5% bleach solution. Gloves
were changed between each tissue sample. DNA contamina-
tion was avoided using aeroguard filter tips (TipOne; Starlab,
Bagneux, France) and individually self-sealing PCR tubes
(Starlab, Bagneux, France), irradiated with UV light at 254 nm
for 10 minutes to inactivate extraneous DNA. Negative con-
trols (water during the amplification step and an uninfected
mouse heart tissue sample during the extraction protocol)
were included every five samples for each experiment to mon-
itor potential contamination. If amplification occurred in any of
the negative controls, the PCR was repeated [33]. All samples
were amplified in duplicate to allow a large number of clones
to be sequenced.
Cloning, DNA sequencing and sequence analysis
The 16S rDNA amplicons were inserted into a vector using a
cloning kit (pGEM-T vector; Promega, Madison, WI, USA), in
accordance with the manufacturer's instructions. 16S rDNA-
containing clones were grown in Nunc microtiter plates con-
taining 150 μl of 2 × Luria-Bertani medium supplemented with
10% glycerol and ampicillin (100 μg/ml). Insert amplifications
were performed using the GE Healthcare amplification kit by
the RCA (rolling circle amplification) method (GE Healthcare,
formerly Amersham). Amplicons were purified and then
sequenced using the commercial BigDye Terminator v3.1 kit
(Applied Biosystems) on a 3730XL sequencer (Applied Bio-
systems). The resulting 16S rDNA clones sequences were
compared to sequences in the European Molecular Biology
Laboratory (EMBL) databases using BLAST (basic local align-
Table 1
Demographic and clinical features of the study patients
Diagnosis 
(patients; n = 28)
Median disease duration 
(months [range])
Actual age or median age 
(years [range])
Sex or sex ratio 
(M/F)
Clinical details
ReA (n = 6) 2 (1–6) 35 (20–50) 5:1
1 28 M Sexually acquired ReA;Ct IgG positive serologya; 
Ct-positive PCRb
2 22 M Sexually acquired ReA; Ct IgG positivea
3 40 F Sexually acquired ReA; Ct IgG positive serologya
4 20 M Sexually acquired ReA; Ct IgG positive serologya; 
B27+c
5 50 M Sexually acquired ReA; Ct IgG positive serologya; 
Ct positive PCRb; B27+
6 30 M Sexually-acquired ReA; Ct IgG positive serologya
UA (n = 9) 25 (2–60) 40 (22–59) 5:4 -
RA (n = 7) 66 (12–228) 44 (39–53) 2:5 -
OA (n = 6) 14 (12–24) 58 (44–70) 5:1 -
aSerology positivity was determined by microimmunofluorescence assay. bChlamydia PCR in genital swabs was determined by Cobas Amplicor 
PCR assay (Roche Diagnostics Molecular Systems, Inc, CA, USA). cHLA-B27 positivity was determined using a microcytotoxicity assay. Ct, 
Chlamydia trachomatis; RA, rheumatoid arthritis; ReA, reactive arthritis; OA, osteoarthritis; UA, undifferentiated arthritis.Arthritis Research & Therapy    Vol 10 No 2    Siala et al.
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ment search tool) and then checked for chimera using ribos-
omal database project II software [34].
Stastistical analysis
Data were compared by Fisher's exact test using Epi Info soft-
ware, version 6.04a (Centers for Disease Control and Preven-
tion, Atlanta, GA, USA). P  < 0.05 was considered to be
statistically significant.
Results
PCR positivity by the broad-range PCR amplification 
system
Because PCR and extraction controls were negative, our
results could be interpretated accurately. Amplification prod-
ucts of the 16S rRNA gene were generated from 21 of the 28
ST samples (75%) using broad-range PCR. Amplicons were
detected in all samples from the six patients with ReA (100%)
and nine with UA (100%). In the control group, bacterial 16S
rDNA was amplified in ST samples from three of the seven
patients with RA (43%) and from three of the six with OA
(50%). Accordingly, the proportion of ST samples from ReA
and UA patients yielding positive PCR results was significantly
higher than that of positive ST samples from control group
patients (100% [15/15] versus 46.2% [6/13]; P = 0.001).
Additionally, ReA and UA samples exhibited a higher bacterial
DNA load, as indicated by the signal intensity of the PCR prod-
ucts (Table 2). To enhance the spectrum of DNA from bacte-
rial species detected, at least 24 individual clones from each
sample were sequenced. Additional sequencing was per-
formed if problems were encountered during the cloning of
nonspecific or partial 16S rDNA products. In general, poorer
DNA profiles of bacterial species were obtained from tissue
samples that gave weak PCR signals (Table 2).
Bacterial 16S rDNA sequences identified in synovial 
tissue samples
A broad range of DNAs from bacterial species was detected
in each ST sample (Table 3). Only good quality sequences,
with length ≥ 1,000 nucleotides, were analyzed. Most bacterial
sequences had ≥ 97% sequence similarity with cultivated or
uncultured bacteria. The per cent similarity to best fit
sequence from the database, the accession number and the
sequence length are listed in Table 4.
DNA from a total of 68 individual bacterial species were
detected in ST samples from the patients with ReA and UA,
and 12 DNAs from different bacteria were identified in the
control ST samples. Additionally, DNAs from 20 bacterial spe-
cies were detected in both study and control samples from
patients with ReA, UA, RA, or OA. Therefore, these organisms
are probably common in joint diseases (Table 4). Many
sequences were from commensal bacteria, in particular those
normally found in the skin or the intestinal tract (Propionibac-
terium acnes, E. coli and other coliform bacteria). We also
detected bacterial DNAs from mucosal bacterial flora such as
streptococci, Actinomycetes and Neisseria, and DNAs from
opportunistic pathogens such as Stenotrophomonas mal-
tophilia,  Alcaligenes faecalis,  Achromobacter xylosoxidans
and Acinetobacter spp. in a number of samples. We found
DNAs from organisms that are commonly identified as trigger-
ing ReA, such as Shigella flexneri and  Shigella sonnei
[35,36], in 33.33% of ReA and UA samples, but not in control
samples. S. sonnei DNA was detected in samples from one
ReA and one UA patient. S. flexneri DNA was detected in
samples from two patients with ReA and one with UA. DNA
from  Propionibacterium acnes – an arthritogenic agent
involved in SAPHO (synovitis, acne, pustulosis, hyperostosis,
and osteitis) syndrome, which is an oligoarthritis associated
with acnes and pustilosis [37,38] – was detected in ReA and
UA samples. Detection of this bacterium-derived DNA was
associated with S. sonnei (patient 3) and with S. flexneri
(patient 5). Patient 5 exhibited pustilosis lesions associated
with an urogenital infection-associated arthritis. Despite there
being no history of septic arthritis in his clinical records, we
detected DNAs from Staphylococcus aureus and streptococ-
cal species in the ST sample from patient 7 (a patient with UA).
No genitourinary tract bacterial sequences (for example, C.
trachomatis) were detected in our patient samples. This was
unexpected, especially in ReA patients with a preceding uro-
genital infection. We also detected DNAs of several bacterial
species that have previously been described in human infec-
tions but not in arthritis (Table 4). These include DNAs from
Bosea vestrisii, Brevundimonas diminuta, Corynebacterium
tuberculostearicum,  Corynebacterium durum,  Microbacte-
rium oxydans,  Oxalobacter  spp.,  Paracoccus yeei,  Leptot-
richia spp., Enterobacter hormachei, Enterobacter cecorum,
Serratia proteamasculans and Ralstonia spp. Most of these
DNAs were mostly detected in one or more ReA or UA sam-
ples but not in control group samples. DNAs from Serratia pro-
teamasculans and Ralstonia spp were also detected in the
control group. Additionally, we detected DNAs from several
bacterial species that have not previously been reported in
human infection (Table 4). Aquabacterium commune, Blasto-
coccus spp., Halomonas spp., Leucobacter lutti, Novosphin-
gobium spp., Pedomicrobium australicum, Variovorax spp.,
Sphingobacterium asaccharolytica and manganese-oxidizing
bacteria were identified from ReA and UA patient samples.
We detected DNA from Caulobacter leidyia, Curvibacter gra-
cilis and Rhodococcus fasciens in control group samples. We
detected in ST samples some bacterial DNA sequences not
previously characterized by rDNA sequencing since they
exhibit less than 97% similarity to known database sequences.
For example, DNA from the candidate division OP10 bacte-
rium was detected in three ReA patients and four UA patients,
but not in control group. We could find no clear association
between the presence of these bacterial DNA and clinical
symptoms.Available online http://arthritis-research.com/content/10/2/R40
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Discussion
We investigated the presence of bacterial DNA in ST samples
from patients with ReA and UA, using 16S rRNA PCR, cloning
and sequencing. This is, to our knowledge, the first study using
the full-length 16S rRNA gene as a target for broad-spectrum
PCR to detect bacterial DNA in synovial samples.
We extracted DNA from ST samples from 28 patients with
arthritis. We found bacterial DNA in 21 (75%) of these
patients, using stringent sterility and anti-contamination tech-
niques. Previous studies, using PCR assays with universal
16S rDNA primers, identified lower proportions of human syn-
ovial samples containing bacterial DNA: 42% of synovial fluid
and ST samples in one study [18], and 10% of ST samples in
another [17]. Our high proportion of bacterial DNA in ST sam-
ples from our patients may be due to the use of the primer pair
(Bac08F/Uni1390R) as well as the use of the T4 Gene 32
Protein, which may increase the yield of PCR products [30-
32].
Sequence analysis of the PCR-positive samples revealed the
presence of a mixture of bacterial DNA in synovial samples
from patients with ReA, UA, RA or OA. These findings are sim-
ilar to those reported in previous studies [12,14,17,39]. A sig-
nificant disadvantage of broad-range PCR is the tendency to
yield false-positive results [33,40]. In fact, we undertook strin-
gent precautionary measures at each step (as presented in
Materials and methods; see above) to prevent contamination.
In addition, the MagNAPure system used is a rapid, closed,
automated and standardized method for DNA extraction, elim-
Table 2
Summary of PCR results and cloning details
Patient PCR intensity scorea Total number of clones sequenced Number of obtained bacterial DNA sequences
ReA
1 ++++ 47 38
2 +++ 96 36
3 +++ 84 50
4 +++ 104 48
5 +++ 34 26
6 ++++ 24 24
UA
7+ + 1 0 5 4 8
8+ + 1 1 4 4 1
9+ + 7 2 4 2
10 ++ 75 25
11 ++ 96 46
12 ++ 74 34
13 ++ 118 42
14 ++ 60 28
15 ++ 101 49
RA
16 ++ 48 40
17 + 96 35
18 + 48 11
OA
19 + 48 31
20 + 72 18
21 + 48 5
aSemi-quantification of intensity of the 16S rDNA amplification products, visualized using ethidium bromide staining after agarose gel 
electrophoresis: '+' indicates barely visible band, and '++++' indicates maximal intensity. OA, osteoarthritis; RA, rheumatoid arthritis; ReA, 
reactive arthritis; UA, undifferentiated arthritis.Arthritis Research & Therapy    Vol 10 No 2    Siala et al.
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Table 3
Details of bacterial species-derived DNA sequences identified in each patient*
Patient Total number of bacterial 
DNA sequences
DNA sequences identified in each patient
ReA
13 8 9  ×  Escherichia coli, 5 × Propionibacterium acnes, 4 × Stenotrophomonas maltophilia, 3 × γ 
proteobacterium, 2 × Afipia genosp, 2 × Escherichia spp., 2 × swine manure bacterium, 2 × uncultured β 
proteobacterium, 2 × uncultured candidate division OP10 bacterium, 1 × Alcaligenes faecalis, 1 × α 
proteobacterium, 1 × Brevundimonas diminuta, 1 × Pseudomonas sp., 1 × Ralstonia sp., 1 × Shigella sp., 
1 × Sphingomonas sp.
23 6 1 4  ×  Escherichia coli, 5 × Bradyrhizobium elkanii, 4 × swine manure bacterium, 3 × Sphingomonas 
asaccharolytica, 2 × Pseudomonas poae, 2 × Ralstonia spp., 2 × uncultured Flavobacterium spp., 2 × 
uncultured Sphingobacterium spp., 1 × Flavobacterium mizutaii, 1 × Pseudomonas sp.
35 0 8  ×  Alcaligenes faecalis, 7 × γ proteobacterium, 7 × Stenotrophomonas maltophilia, 6 × Rhodococcus 
spp., 6 × swine manure bacterium, 5 × Shigella sonnei, 5 × Propionibacterium acnes, 4 × unclassified 
proteobacteria, 2 × Serratia proteamaculans
44 8 2 5  ×  Aquabacterium commune, 4 × Afipia genosp, 4 × swine manure bacterium, 2 × Escherichia spp., 2 × 
γ proteobacterium, 2 × Propionibacterium acnes, 2 × Stenotrophomonas maltophilia, 1 × Acinetobacter 
baumannii, 1 × α proteobacterium, 1 × Flavobacterium mizutaii, 1 × Ralstonia sp., 1 × Shigella flexneri, 1 
× Variovorax sp., 1 × uncultured candidate division OP10 bacterium
52 6 6  ×  Aquabacterium commune, 6 × γ proteobacterium, 3 × Afipia genosp, 2 × Propionibacterium acnes, 2 
× Ralstonia spp., 2 × swine manure bacterium, 1 × Shigella flexneri, 1 × Shigella sp., 1 × Staphylococcus 
haemolyticus, 1 × Stenotrophomonas maltophilia, 1 × uncultured eubacterium
62 4 1 0  ×  Escherichia coli, 3 × γ proteobacterium, 2 × Leucobacter luti, 2 × Staphylococcus spp., 2 × swine 
manure bacterium, 2 × uncultured candidate division OP10 bacterium, 1 × Ralstonia sp., 1 × 
Stenotrophomonas maltophilia, 1 × uncultured Sphingobacterium sp.
UA
74 8 7  ×  Stenotrophomonas maltophilia, 6 × swine manure bacterium, 4 × Rhodococcus spp., 4 × 
Staphylococcus spp., 4 × Streptococcus infantis, 3 × Propionibacterium acnes, 3 × Bosea vestrisii, 2 × 
Afipia genosp, 2 × Blastococcus spp., 2 × Leptotrichia spp., 1 × Aeromonas sp., 1 × Actinomyces sp., 1 
× Corynebacterium durum, 1 × Kingella oralis, 1 × Microbacterium oxydans, 1 × Neisseria flava, 1 × 
Pirellula sp., 1 × Shigella sp., 1 × Staphylococcus aureus, 1 × Streptococcus mitis, 1 × Streptococcus 
sanguinis
84 1 1 3  ×  Escherichia coli, 6 × Bradyrhizobium elkanii, 5 × Sphingomonas spp., 4 × γ proteobacterium, 3 × 
Enterobacter hormaechei, 3 × Stenotrophomonas maltophilia, 2 × Corynebacterium tuberculostearicum, 1 
× Enterococcus cecorum, 1 × Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × uncultured soil 
bacterium, 1 × uncultured Sphingobacterium sp.
94 2 1 1  ×  Escherichia coli, 7 × uncultured Sphingobacterium spp., 4 × Flavobacterium mizutaii, 6 × uncultured 
Flavobacterium spp., 3 × γ proteobacterium, 2 × Corynebacterium, tuberculostearicum, 2 × Ralstonia spp., 
2 × Stenotrophomonas maltophilia, 1 × Paracoccus yeei, 1 × Pseudomonas poae, 1 × Shigella sonnei, 1 
× Streptococcus mitis, 1 × manganese-oxidizing bacterium
10 25 10 × Escherichia coli, 3 × uncultured Flavobacterium spp., 2 × uncultured Sphingobacterium spp., 2 × 
Bacteroidetes bacterium, 2 × Flavobacterium mizutaii, 1 × Oxalobacter sp., 1 × Shigella flexneri, 1 × 
Shigella sp., 1 × Stenotrophomonas maltophilia, 1 × uncultured α proteobacterium, 1 × uncultured 
candidate division OP10 bacterium
11 46 9 × Escherichia coli, 5 × Acinetobacter spp., 5 × Stenotrophomonas maltophilia, 5 × uncultured γ 
proteobacterium, 3 × uncultured Sphingobacterium spp., 3 × Pseudomonas spp., 2 × Flavobacterium 
mizutaii, 2 × Propionibacterium acnes, 2 × swine manure bacterium 37–8, 2 × uncultured Flavobacterium 
spp., 1 × Aeromonas sp., 1 × Caulobacter endosymbiont of Tetranychus urticae, 1 × Acinetobacter 
schindleri, 1 × manganese-oxidizing bacterium, 1 × γ proteobacterium, 1 × uncultured Sphingobacterium 
sp., 1 × unclassified proteobacterium, 1 × uncultured candidate division OP10 bacteriumAvailable online http://arthritis-research.com/content/10/2/R40
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inating many manual steps and thus minimizing the risk for
cross-contamination. PCR and extraction controls consistently
yielded negative results; thus, the PCR products detected in
positive samples should derive only from tissue-associated
bacterial rRNA genes.
Most commensal and environmental bacterial 16S rDNA
sequences detected in our broad-range PCR analysis of syn-
ovial samples belong to species identified in previous studies
[12,14,17,18]. Some of these were found in both the patients
and control group (for instance, Stenotrophomonas mal-
tophilia and E. coli), implying that their presence in the syn-
ovium is not disease specific; rather, they are likely to be
opportunistic colonizers of tissue that was already diseased.
E. coli DNA was detected in synovial samples from several
patients (three with ReA, eight with UA, three with RA and two
12 34 13 × Escherichia coli, 4 × Corynebacterium coyleae, 3 × Sphingomonas spp., 2 × γ proteobacterium, 2 × 
Ralstonia spp., 2 × Shigella spp., 2 × swine manure bacterium, 2 × uncultured Sphingobacterium spp., 1 
× Flavobacterium mizutaii, 1 × Klebsiella sp., 1 × Propionibacterium acnes, 1 × unclassified 
enterobacteria
13 42 18 × Escherichia coli, 4 × uncultured Sphingobacterium spp., 3 × Stenotrophomonas maltophilia, 2 × 
Aeromonas spp., 2 × Flavobacterium mizutaii, 2 × gamma proteobacterium, 2 × Ralstonia spp., 2 × 
uncultured candidate division OP10 bacterium, 1 × Alcaligenes faecalis, 1 × Acinetobacter sp., 1 × 
Halomonas sp., 1 × Stenotrophomonas sp., 1 × swine manure bacterium, 1 × Sphingomonas sp., 1 × 
uncultured Flavobacterium sp.
14 28 8 × Escherichia coli, 2 × Bradyrhizobium japonicum, 2 × γ proteobacterium, 2 × α proteobacterium, 2 × 
Stenotrophomonas maltophilia, 2 × Sphingomonas spp., 2 × Corynebacterium durum, 1 × Achromobacter 
xylosoxidans, 1 × Bacteroidetes bacterium, 1 × β proteobacterium, 1 × Bradyrhizobium elkanii, 1 × 
Novosphingobium spp., 1 × Paracoccus spp., 1 × unclassified Rhodocyclaceae, 1 × uncultured 
Sphingobacterium sp.
15 49 17 × Escherichia coli, 5 × Shigella spp., 4 × Stenotrophomonas maltophilia, 4 × unclassified 
Rhodocyclaceae, 3 × swine manure bacterium, 3 × uncultured candidate division OP10 bacterium, 2 × 
uncultured Sphingobacterium spp., 2 × uncultured Sphingobacterium spp., 2 × Rhodococcus spp., 1 × 
Alcaligenes sp., 1 × α proteobacterium, 1 × Bradyrhizobium japonicum, 1 × Ralstonia sp., 1 × 
Flavobacterium mizutaii, 1 × γ proteobacterium, 1 × Pedomicrobium australicum
RA
16 40 15 × Escherichia coli, 5 × swine manure bacterium, 4 × Ralstonia spp., 3 × uncultured Flavobacterium 
spp., 2 × Acinetobacter spp., 2 × Antarctic bacterium, 2 × Flavobacterium mizutaii, 1 × Actinomyces 
naeslundii, 1 × Alcaligenes faecalis, 1 × Bacteroidetes bacterium, 1 × Caulobacter sp., 1 × 
Corynebacterium aurimucosum, 1 × Shigella sp., 1 × uncultured α proteobacterium
17 35 6 × Escherichia coli, 5 × Shigella spp., 4 × Bradyrhizobium elkanii, 4 × uncultured Sphingobacterium 
spp., 3 × Ralstonia spp., 3 × uncultured Flavobacterium spp., 2 × γ proteobacterium, 2 × swine manure 
bacterium, 1 × Alcaligenes sp., 1 × Caulobacter sp., 1 × Pseudomonas sp., 1 × Rhodococcus fascians, 1 
× Serratia proteamaculans, 1 × Streptococcus thermophilus
18 11 7 × Escherichia coli, 2 × Stenotrophomonas maltophilia, 1 × γ proteobacterium, 1 × Ralstonia sp.,
OA
19 31 7 × Escherichia coli, 7 × swine manure bacterium, 5 × Alcaligenes faecalis, 4 × Pseudomonas poae, 3 × 
Bradyrhizobium elkanii, 2 × Stenotrophomonas maltophilia, 1 × Caulobacter leidyia, 1 × Curvibacter 
gracilis, 1 × γ proteobacterium
20 18 7 × Escherichia coli, 7 × uncultured Flavobacterium spp., 2 × uncultured Sphingobacterium spp., 1 × 
uncultured delta proteobacterium, 1 × Shigella sp.
21 5 2 × Alcaligenes spp., 1 × Achromobacter xylosoxidans, 2 × Brucellaceae bacterium
Table 3 (Continued)
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Table 4
Bacterial species identified by sequencing of cloned 16S rDNA
Bacterium-derived DNA identified in ST 
samples
Number of patients in whom bacterial 
DNAs were detected
Accession numbera Length of the sequenceb % Similarityc
Bacteria identified in ReA and UA patients (n = 68)
Bacteria previously detected in arthritis
Acinetobacter baumannii (1 ReA) AY738400 1,384 99.86
Acinetobacter schindleri (1 UA) AJ278311 1,367 98.83
Actinomyces sp. (1 UA) AY008315 1,420 98.73
Aeromonas sp. (1 UA) U88656 1,396 99.36
Aeromonas sp. (2 UA) AF099027 1,336 98.58
Afipia genosp 7 (1 UA) U87773 1,336 97.38
Afipia genosp 9 (1 ReA) U87779 1,335 99.62
Afipia genosp 9 (1 ReA) U87775 1,256 97.00
Afipia genosp 9 (1 ReA) U87777 1,337 99.55
Corynebacterium coyleae (1 UA) X96497 1,360 99.04
Escherichia coli (1 ReA) AP009048 1,389 99.71
Escherichia sp. (2 ReA) DQ337503 1,390 99.71
Klebsiella sp. (1 UA) U32868 1,387 99.57
Neisseria flava (1 UA) AJ239301 1,338 98.43
Paracoccus sp. (1 UA) AY745834 1,308 99.92
Propionibacterium acnes (1 ReA+ 2 UA) AB108477 1,377 100.00
Pseudomonas sp. (1 UA) DQ079062 1,388 98.63
Ralstonia sp. (1 ReA) DQ227340 1,382 100.00
Rhodococcus sp. (2 UA) AF420412 1,365 99.85
Shigella flexneri (2 ReA + 1 UA) X96963 1,389 99.71
Shigella sonnei (1 ReA) X96964 1,389 99.86
Shigella sonnei (1 UA) CP000038 1,390 97.70
Sphingomonas sp. (2 UA) AJ864842 1,329 99.77
Staphylococcus aureus (1 UA) L37597 1,400 99.93
Staphylococcus haemolyticus (1 ReA) AP006716 1,400 99.93
Staphylococcus sp. (1 ReA) AJ704792 1,400 99.72
Staphylococcus sp. (1 UA) AB177642 1,399 99.71
Stenotrophomonas sp. (1 UA) AF409004 1,382 99.13
Streptococcus infantis (1 UA) AY485603 1,385 99.64
Streptococcus mitis (2 UA) AY005045 1,385 99.57
Streptococcus sanguinis (1 UA) AF003928 1,397 99.79Available online http://arthritis-research.com/content/10/2/R40
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Bacteria not previously detected in arthritis
Bosea vestrisii (1 UA) AF288302 1,336 99.70
Brevundimonas diminuta (1 ReA) X87274 1,308 99.62
Corynebacterium durum (2 UA) AF537593 1,364 99.05
Corynebacterium 
tuberculostearicum
(2 UA) AJ438044 1,368 99.71
Enterococcus cecorum (1 UA) AF061009 1,398 99.43
Enterobacter hormaechei (1 UA) AY995561 1,395 99.64
Kingella oralis (1 UA) L06164 1,389 98.78
Leptotrichia sp. (1 UA) AY008309 1,359 99.85
Microbacterium oxydans (1 UA) AJ717356 1,374 98.69
Oxalobacter sp. (1 UA) AJ496038 1,387 98.05
Paracoccus yeei (1 UA) AY014169 1,309 99.77
Bacteria not previously detected in humans
Aquabacterium commune (2 ReA) AF035054 1,367 99.85
Blastococcus sp. (1 UA) AJ316573 1,357 97.27
Bradyrhizobium japonicum (2 UA) BA000040 1,333 99.17
Halomonas sp. (1 UA) AJ302088 1,389 98.85
Leucobacter luti (1 ReA) AM072819 1,369 98.39
Novosphingobium sp. (1 UA) AB177883 1,335 97.00
Pedomicrobium australicum (1 UA) X97693 1,324 98.64
Pirellula sp. (1 UA) X81945 1,322 96.14*
Sphingobacterium 
asaccharolytica
(1 ReA) Y09639 1,324 98.11
Variovorax sp. (1 ReA) AB196432 1,383 99.28
Uncultured bacteria
α Proteobacterium (1 ReA) AY162046 1,308 99.62
α Proteobacterium (1 ReA+ 21 UA) AY162053 1,332 99.85
β Proteobacterium (1 UA) AF236007 1,371 99.71
Caulobacter endosymbiont of 
Tetranychus urticae
(1 UA) AY753176 1,334 99.63
γ Proteobacterium (1 ReA) AY162032 1,395 97.42
Manganese-oxidizing 
bacterium
(2 UA) U53824 1,320 99.85
Uncultured α proteobacterium (1 UA) AF445680 1,329 97.06
Uncultured β proteobacterium (1 ReA) AF445700 1,372 99.78
Table 4 (Continued)
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Uncultured candidate division 
OP10 bacterium
(3 ReA + 4 UA) AF418946 1,297 90.98*
Uncultured γ proteobacterium (1 UA) AJ318146 1,397 97.35
Uncultured γ proteobacterium (1 UA) AF324537 1,387 99.71
Unclassified 
Enterobacteriaceae
(1 UA) AY375058 1,391 97.56
Uncultured eubacterium (1 ReA) AJ292601 1,334 96.93
Uncultured soil bacterium (1 UA) AF423262 1,295 96.91
Unclassified proteobacteria (1 ReA) AY820722 1,383 96.46*
Unclassified Rhodocyclaceae (2 UA) AY328759 1,388 99.42
Bacteria identified in control group (RA and OA patients; n = 12)
Bacteria previously detected in arthritis
Actinomyces naeslundii (1 RA) AJ234050 1,392 97.84
Brucellaceae bacterium (1 OA) AY353698 1,333 99.17
Corynebacterium aurimucosum (1 RA) AY536427 1,369 99.34
Streptococcus thermophilis (1 RA) AY188354 1,397 99.36
Bacteria not previously detected in arthritis
Alcaligenes sp. (1 OA) AF430122 1,386 98.63
Caulobacter sp. (2 RA) AJ227775 1,323 99.70
Bacteria not previously detected in humans
Caulobacter leidyia (1 OA) AJ227812 1,324 100.00
Curvibacter gracilis (1 OA) AB109889 1,379 99.71
Rhodococcus fascians (1 RA) Y11196 1,365 99.71
Uncultured bacteria
Antarctic bacterium (1 RA) AJ440974 1,321 98.86
Uncultured α proteobacterium (1 RA) AJ604541 1,324 98.60
Uncultured δ proteobacterium (1 RA) AY921777 1,402 97.22
Common bacteriad (n = 20)
Bacteria previously detected in arthritis
Achromobacter xylosoxidans (1 UA + 1 OA) AF439314 1,378 99.71
Acinetobacter sp. (2 ReA + 1 RA) Z93442 1,365 99.35
Alcaligenes faecalis (2 ReA+ 1 UA+ 1 RA+ 1 OA) AY548384 1,385 99.93
Escherichia coli (3 ReA+ 7 UA+ 1 RA+ 2 OA) V00348 1,393 100.00
Escherichia coli (3 ReA+ 9 UA+ 3 RA+ 2 OA) U00096 1,390 100.00
Flavobacterium mizutaii (2 ReA + 7 UA + 1 RA) AJ438175 1,384 94.44*
Pseudomonas sp. (2 ReA + 1 UA + 1 RA) AJ237965 1,376 99.56
Table 4 (Continued)
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with OA). Other studies have demonstrated that commensal
organisms such as E. coli, widely distributed in the human gut,
can colonize inflamed joints [41-44]. However, a better under-
standing of the contribution made by intestinal microflora to
human biology is needed to elucidate the potential role played
by microflora in the pathogenesis of ReA [41-44].
We detected DNAs of some bacteria that have not previously
been described in human synovial samples, such as Blasto-
coccus spp., Leucobacter lutti, Halomonas spp., Rhodococ-
cus fascians and manganese-oxidizing bacteria (Table 4).
These organisms have an environmental source (soil, plant and
water). Other 16S rRNA gene sequences showing less than
97% sequence similarity with bacterial sequences from the
EMBL database and affiliated with noncultivated bacteria were
detected. Thus, we found DNAs from uncultured candidate
division OP10 bacteria in ReA and UA samples, but not in con-
trol samples. However, the synovium is probably an interfacial
zone that can be colonized by bacterial DNAs originating from
the environment and the endogenous microflora [37]; indeed,
only a proportion of resident commensal micro-organisms in
the gut have been identified [44].
Our approach of cloning and near full-length sequencing of
bacterial 16S rDNA might confirm the presence of such DNAs
of bacteria not considered to be human pathogens in the syn-
ovium. Their significance remains unclear, however, and fur-
ther investigations will be required to determine the
pathogenic relevance of these findings.
We detected DNA from Shigella flexneri and Shigella sonnei
– micro-organisms that are known to trigger ReA – in ReA
and/or UA samples but not in control samples. Shigella DNA
positive patients had no clinical signs of previous intestinal
infection with an enteric organism. These patients may have
been asymptomatic, or the preceding gastrointestinal symp-
toms may have been mild and overlooked by the patients [6].
It is possible that enteric organisms may move from asympto-
matic primer sites of infection to the synovium in such patients
[6]. Most Shigella ReA cases are caused by S. flexneri [35],
but sporadic cases associated with S. sonnei and S. dysente-
riae have been described [4,35]. The most recent published
case of S. sonnei related ReA was attributed to sexual trans-
mission of the pathogen [36]. In our study, we detected S.
sonnei DNA in one ReA patient presenting with an urogenital
Stenotrophomonas maltophilia (3 ReA + 4 UA + 1 OA) AJ293470 1,395 99.93
Shigella sp. (2 ReA+ 4 UA+ 2 RA+ 1 OA) DQ337523 1,392 99.93
Bacteria not previously detected in arthritis
Alcaligenes sp. (1 UA + 1 OA) AY672759 1,345 99.11
Bradyrhizobium elkanii (1 ReA+ 2 UA+ 1 RA+ 1 OA) AY904749 1,338 99.93
Pseudomonas poae (1 ReA + 1 OA) AJ492829 1,386 99.93
Ralstonia sp. (5 ReA + 4 UA + 3 RA) AB045276 1,388 100.00
Serratia proteamaculans (1 ReA + 1 RA) AJ233435 1,387 97.76
Bacteria not previously detected in humans
Uncultured bacteria
Bacteroidetes bacterium (2 UA + 1 RA) AY395022 1,196 97.49
γ proteobacterium (2 ReA + 3 UA + 1 OA) AY162042 1,399 99.88
γ proteobacterium (4 ReA + 6 UA + 2 RA) AY162068 1,397 99.93
Swine manure bacterium (6 ReA+ 5 UA+ 2 RA+ 1 OA) AY167969 1,388 100.00
Uncultured Flavobacterium 
sp.
(1 ReA+ 4 UA+ 2 RA+ 1 OA) DQ168834 1,193 97.15
Uncultured Sphingobacterium 
sp.
(2 ReA+ 8 UA+ 1 RA+ 1 OA) AB076874 1,390 94.31*
Number in brackets after species names indicate the number of patient set from whom bacteria were detected. aAccession number of the 
bacterial species in the database. bLength of alignment on which the 16S rDNA inserted sequence and the corresponding sequence in the 
database are similar. cIn the '% similarity' column, asterisks indicate highligh instances where the % similarity is below 97%. dThe 'Common 
bacteria' row shows the bacteria identified in ReA, UA, RA and OA patients. OA, osteoarthritis; RA, rheumatoid arthritis; ReA, reactive arthritis; ST, 
synovial tissue; UA, undifferentiated arthritis.
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infection, which is consistent with the possibility that this spe-
cies could be related to sexual transmission.
Propionibacterium acnes sequences were detected in syno-
vial samples of one ReA patient with pustular lesions and two
UA patients in whom we did not detect any other causative
bacteria derived DNA. Thus, the presence of P. acnes DNA in
these patients is likely to be either disease specific or due to
opportunistic colonization of the inflamed joints. This bacte-
rium is part of the normal skin flora. It was recently identified in
articular samples from patients with SAPHO (synovitis, acne,
pustulosis, hyperostosis, and osteitis) syndrome, which is
often regarded to be a form of spondyloarthropathy, suggest-
ing an infectious origin of this syndrome [37,38]. Our findings
also suggest that this organism can access the joints.
ReA-related genitourinary bacterial species, including chlamy-
dial sequences, were not detected in any patient samples,
despite the large number of clones sequenced and analyzed
for each sample. Thus, it is possible that not all bacterial DNAs
present within the joint were detected. Indeed, even for
arthritic patients with related urogenital infections, the detec-
tion of genital infectious agents by broad-range PCR may have
been masked by the presence of other bacterial DNAs. Thus,
bacteria appear to move from various anatomic sites such as
gut to the joints. This is consistent with the detection of E. coli
sequence in many of the synovial samples. In enteric ReA,
active bowel inflammation affects the barrier function of the
gut wall, allowing gut flora to access systemic sites [45].
Moreover, most of the patients were taking nonsteroidal drugs,
which can impair gut permeability and mucosal competence.
We have shown that sequences from bacterial species that
are known to be involved in the onset of arthritis represented
a minority of the sequences detected in ST samples from
patients with ReA. In addition, their presence was associated
with DNAs from commensal and environmental bacterial flora.
This raises the question about the role that this variety of intra-
articular bacterial DNA plays in the pathogenesis of ReA and
other forms of arthritides. However, detection of bacterial
DNAs in the ST of patients with arthritis does not necessarily
reflect the presence of complete bacterial genome, the pres-
ence of infectious bacteria or the potential of bacterial replica-
tion, or indicate whether detected DNA is related to the
synovial pathology [2]. Within this context, the presence of
multiple bacterial DNAs in patient joints does not substantiate
a multibacterial infection that could ensue in these patients.
Our detection of bacterial DNA in synovia of both control and
study patient samples may indicate that a low level of 'back-
ground' bacterial DNA is usually present in synovial material
and that such DNAs do not necessarily cause synovitis
[17,46]. Such a variety of bacterial DNA could be due to the
passive transfer of various bacterial products within phago-
cytic cells to the inflamed joint. Consistent with this, bacterial
fragments have previously been detected – using immunohis-
tochemical techniques – in macrophages from spleen of rats
and humans and in synovium-derived macrophages from
patients with various arthropathies [41,47,48]. Nonspecific
migration of inflammatory cells containing bacterial particles
into synovium could promote synovial inflammation [17]. On
the other hand, bacterial DNA itself might trigger an immune
response, and thus may induce synovitis. It has been shown
that experimental intra-articular injection of some bacterial
DNA (Escherichia coli, Staphylococcus aureus) or simply of
nonmethylated CpG motifs is sufficient to trigger arthritis in
mice [49-51]. The hypothesis is that bacterial DNA may be
directly responsible for part of the synovial inflammation. This
merits further investigations in humans, particularly to assess
whether the quantity of bacterial DNA required to induce
arthritis is comparable with the 'inoculum' observed in vitro in
ReA and other arthritides.
Conclusion
Broad-range PCR, sequencing and cloning are essential tech-
niques for the characterization of the microbial environment in
joints. This is the first study to use a broad-range 1,400 base
pair 16S rDNA PCR coupled to automated DNA extraction to
identify bacterial nucleic acid present in the joints of patients
with ReA and other forms of arthritis. Our study provides a
potential overall picture of the detailed presence of bacterial
DNA in arthritic joint. Cloning procedures allowed the identifi-
cation of known ReA-triggering organisms, unknown patho-
gens, and potentially novel bacterial species not previously
associated with ReA and other forms of arthritis
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